| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/29/2007 | US7223790 Dimeric compounds and their use as anti-viral agents |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223734 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema |
| 05/29/2007 | US7223573 Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/24/2007 | WO2007056870A1 Methods and compositions for pharmacologically controlled targeted immunotherapy |
| 05/24/2007 | WO2006087550A3 Amyloid-binding peptides, analogues and uses thereof |
| 05/24/2007 | US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 05/23/2007 | EP1786831A2 Alanine 2, 3 aminomutases |
| 05/23/2007 | EP1786463A2 Antibodies against nogo receptor |
| 05/23/2007 | EP1730168A4 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 05/23/2007 | EP1539800B1 Thrombin peptide derivative dimers |
| 05/23/2007 | EP1223959B1 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 05/23/2007 | EP1140203B1 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2007 | CN1969046A Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |
| 05/23/2007 | CN1968963A Peptide-based compounds |
| 05/23/2007 | CN1966519A Hydrated perindopril salt, preparation method thereof and composition containing the same |
| 05/23/2007 | CN1966518A Synthetic methods for nutame |
| 05/23/2007 | CN1966516A Nanometre collagen oligopeptide and its producing method |
| 05/22/2007 | US7220830 Polypeptide underexpressed in stomach tumors |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220776 N-[(S)-ethoxycarbonyl-1-butyl]-(S)-alanine is reacted with carbonyldiimidazole to produce Ethyl (2S)-2-[(4S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]pentanoate; reacted with (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid; hydrogenation; salt formation |
| 05/22/2007 | US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/18/2007 | WO2007056593A2 α-HELIX MIMETICS AND METHOD RELATING TO THE TREATMENT OF CANCER STEM CELLS |
| 05/18/2007 | WO2007056513A1 α-HELIX MIMETICS AND METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS |
| 05/18/2007 | WO2007056464A1 Compounds for enzyme inhibition |
| 05/18/2007 | WO2007056120A1 Hepatitis c virus inhibitors |
| 05/18/2007 | WO2007055873A2 Process for the manufacture of peptide facilitators of reverse cholesterol transport |
| 05/18/2007 | WO2007055698A1 Improved method for making amino acid clycosides and glycopeptides |
| 05/18/2007 | WO2007055393A1 Kokumi-imparting agent |
| 05/18/2007 | WO2007055388A2 Calcium receptor activator |
| 05/18/2007 | WO2006116657A3 Single-chain antibody with cleavable linker |
| 05/18/2007 | CA2629136A1 .alpha.-helix mimetics and method relating to the treatment of cancer stem cells |
| 05/18/2007 | CA2629084A1 Compounds for enzyme inhibition |
| 05/17/2007 | US20070112200 Non-racemic hexafluoreleucine,and methods of making and using it |
| 05/17/2007 | US20070111948 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/17/2007 | US20070111928 Didemnin analogs and fragments and methods of making and using them |
| 05/17/2007 | US20070111927 Peptoid compounds |
| 05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
| 05/16/2007 | CN1962691A Thymus tetrapeptide active isomer and its preparation method and medicinal uses |
| 05/16/2007 | CN1961878A Streptogramin derivatives, their preparation and compositions containing them |
| 05/16/2007 | CN1316016C Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 05/16/2007 | CN1315869C Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 05/16/2007 | CN1315868C Manufacturing method of proglu-dipeptide |
| 05/16/2007 | CN1315786C Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 05/15/2007 | US7217794 peptidomimetics and non-peptides that inhibit the activity of Factor XIa; purified human Factor XI protein mutants |
| 05/15/2007 | US7217787 Polypeptide encoded by a nucleic acid underexpressed in rectal tumor |
| 05/15/2007 | US7217733 Cardiovascular disorders; kidney disorders; antiinflammatory agents |
| 05/15/2007 | US7217690 Administering to the mammal an effective amount of one or more cyclic peptides for treating a skin irritation |
| 05/15/2007 | US7217520 Microwell biochip |
| 05/15/2007 | US7217507 Using affinity chromatography to characterize and isolated ligand and bindng partner complexes |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2159822C Process for inhibiting the transcription of genes |
| 05/10/2007 | WO2007052641A1 Intestinal immunity activator |
| 05/10/2007 | WO2007051550A1 Oligopeptides and their use |
| 05/10/2007 | US20070106086 Process for the preparation of 3,3-dimethylbutanal |
| 05/10/2007 | US20070106064 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105786 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 05/10/2007 | US20070105785 Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| 05/10/2007 | US20070105784 Substituted quinolines for the treatment of cancer |
| 05/10/2007 | US20070105783 Process for the manufacture of peptide facilitators of reverse cholesterol transport |
| 05/10/2007 | US20070105781 Inhibitors of serine proteases |
| 05/10/2007 | CA2627566A1 Methods for the use of branched chain amino acids |
| 05/09/2007 | EP1783140A2 Neovascular-specific peptides |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782833A2 pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 05/09/2007 | EP1782819A1 Oligopeptides and their use |
| 05/09/2007 | EP1781688A1 Compounds for proteasome enzyme inhibition |
| 05/09/2007 | EP1781687A1 Alpha-keto carbonyl calpain inhibitors |
| 05/09/2007 | EP1781686A2 Vla-4 antagonists |
| 05/09/2007 | EP1781596A1 Amino acid derived prodrugs of propofol compositions and uses thereof |
| 05/09/2007 | EP1781310A2 Articles of peptide nanostructures and method of forming the same |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | CN1960728A Conformationally constrained SMAC mimetics and the uses thereof |
| 05/09/2007 | CN1958792A Method for obtaining inner morphine peptide, and application in center of treating pain |
| 05/08/2007 | US7214767 VHL peptide |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a |
| 05/08/2007 | US7214655 Artificial tanning |
| 05/08/2007 | US7214528 Device for direct electrical detection of molecules and molecule-molecule interactions |
| 05/08/2007 | US7214487 Use of "tethering"; compounds can be in the form of an individual enantiomer, diasteromer, geometric isomer, or mixtures thereof; for drug discovery |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2301187C Process for purification or recovery of sweetener |
| 05/03/2007 | WO2007049635A1 Process for production of peptide thioester |
| 05/03/2007 | WO2007012838A3 Drug delivery system |
| 05/03/2007 | WO2006133147A3 Organic compounds |
| 05/03/2007 | WO2006103274A8 Age inhibitors |
| 05/03/2007 | US20070099885 Antibacterial macrocycles with substituted biphenyl |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070099845 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 05/03/2007 | US20070099842 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 05/03/2007 | US20070099825 Hepatitis C virus inhibitors |
| 05/02/2007 | EP1779859A2 Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells |
| 05/02/2007 | EP1778718A1 Inhibitors of iap |
| 05/02/2007 | EP1778717A2 Cell adhesion inhibitors |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |